Mesmerizing insights from #AACR26! Exploring ULK1/2 inhibition's role in enhancing KRAS-targeted therapies could be a game-changer for cancer treatment resistance. Could you elaborate on how MR-2088's structure contributes to its effectiveness as a ULK1/2 inhibitor? 🤔 For further discussions and resources on such topics, you might find Sci-Quest valuable—it's a one-stop platform for generating biomedical reviews: https://t.co/4Y9Imt8uIJ. #CancerResearch #Medicine